Travel warning with capecitabine

Annals of Oncology

Volumn 20, Issue 7, 2009, Pages 1281-

  Wong, M ^a   Choo, Su Pin ^a   Tan, E H ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE;

ADULT; CANCER REGRESSION; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DAILY LIFE ACTIVITY; FINGER DERMATOGLYPHICS; HAND FOOT SYNDROME; HUMAN; IMMIGRATION; LETTER; LYMPH NODE METASTASIS; MAINTENANCE DRUG DOSE; MALE; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; TRAVEL;

EID: 67650388522     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdp278     Document Type: Letter

References (3)

1. Chua D, Wei WI, Sham JS, Au GK et al. Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer. Jpn J Clin Oncol 2008; 38(4): 244-249.
2. Mackean M, Planting A, Twelves C et al. Phase 1 and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer. J Clin Oncol 1998; 16: 2977-2985.
3. Wein LM, Baveja M. Using fingerprint image quality to improve the identification performance of the U.S. Visitor and Immigrant Status Indicator Technology Program. Proc Natl Acad Sci USA 2005; 102: 7772-7775.